Beneficient-A Stock Price, News & Analysis

Beneficient (NASDAQ: BENF) has received an additional delisting notice from Nasdaq due to delayed filing of its Q2 2025 Form 10-Q. This follows previous notifications regarding non-compliance with the $1.00 minimum bid price requirement and delayed filing of FY2025 Form 10-K.

The company has requested a hearing before the Nasdaq Hearings Panel to present its compliance plan and seek an extension. While Beneficient is taking steps to address these issues, there is no guarantee the Panel will approve continued listing.

Beneficient (NASDAQ: BENF) announced significant leadership changes with the separation of its Chairman and CEO roles. Thomas O. Hicks, a private equity pioneer who has overseen more than $50 billion in leveraged acquisitions, has been appointed as Chairman of the Board. James G. Silk has been named interim CEO, bringing over 20 years of financial services experience.

Silk previously served as Beneficient's Executive Vice President and Chief Legal Officer from January 2020 to May 2024, while Hicks has been serving on the Board since 2018. The appointments aim to revitalize the company's momentum and enhance shareholder value through their combined expertise in alternative assets and financial services.

Beneficient (NASDAQ: BENF) has received a delisting notice from Nasdaq due to two compliance issues: failure to maintain the minimum $1.00 bid price requirement and delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

The company plans to request a hearing before the Nasdaq Hearings Panel and seek a stay of any suspension action. During the hearing, Beneficient will present its compliance plan and request an extension. However, there is no guarantee that the Panel will grant the company's request for continued listing.

Beneficient (NASDAQ: BENF) has completed a $1.91 million primary capital transaction with Mendoza Ventures Growth Fund III, LP. The deal represents Ben's third GP Primary transaction of the fiscal year and fourth since launching the program in late 2024.

The Fund received Resettable Convertible Preferred Stock convertible into Ben's Class A common stock. The transaction is expected to increase Ben's ExAlt loan portfolio collateral by $1.91 million. Additionally, Ben entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions.

This initiative is part of Ben's GP Primary Commitment Program, which aims to address up to $330 billion of potential demand for primary commitments in fundraising.

Beneficient (NASDAQ: BENF) has received approval from the Bankruptcy Court for the Southern District of Texas for a settlement agreement resolving all GWG Holdings-related litigation claims against the company, its subsidiaries, and their current and former directors and officers. The settlement, announced on March 10, 2025, will be paid within insurance policy limits and remains subject to approval from the District Court for the Northern District of Texas. The agreement resolves all claims without any admission of fault or liability. While this settles claims in the Bankruptcy Court, other GWG-related claims against parties outside Beneficient remain active, including claims against entities related to Beneficient's founder and CEO, for whom the company has indemnification obligations.

Beneficient (NASDAQ: BENF), a technology platform providing exit solutions and capital services for alternative assets, announced the adjournment of its Annual Meeting of Stockholders from May 28, 2025, to May 29, 2025, at 2:00 p.m. CDT. The meeting was postponed due to insufficient quorum of stockholder shares present. The virtual meeting will be held at cstproxy.com/beneficient/2025.

The Board continues to support all proxy statement proposals as being in stockholders' best interests. Previously submitted proxies remain valid unless revoked, and stockholders who haven't voted can do so until May 28, 2025, at 11:59 p.m. CDT through online voting, telephone, or mail.

Beneficient (NASDAQ: BENF), a tech platform providing exit solutions and capital services for alternative asset holders through its AltAccess platform, has announced an adjournment of its Annual Meeting of Stockholders.

The meeting, previously scheduled for April 30, 2025, has been postponed to May 28, 2025 at 8:00 a.m. Central time due to insufficient quorum. The virtual meeting will be held at cstproxy.com/beneficient/2025.

Stockholders who haven't voted can do so until May 27, 2025, at 11:59 p.m. Central time through:

• Internet: cstproxyvote.com
• Phone: 1-866-894-0536
• Mail: Corporate Secretary, Beneficient, Dallas, Texas

Previously submitted proxies remain valid unless revoked. The Board maintains that all proxy statement proposals are in stockholders' best interests.

Beneficient (NASDAQ: BENF) has announced the closure of a $233,333 primary capital commitment for Cork & Vines Fund I, LP, marking its second GP Primary transaction of the fiscal year. The Fund received Resettable Convertible Preferred Stock convertible into BENF Class A common stock.

This transaction represents Ben's third deal since launching the program in late 2024, expected to increase the collateral for the Company's ExAlt loan portfolio by approximately $233,333. The company also entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions.

Upon closing of the Public Stockholder Enhancement Transactions, this deal is anticipated to add approximately $77,777 to the tangible book value attributable to stockholders. The GP Primary Commitment Program aims to address up to $330 billion of potential demand for primary commitments in fundraising needs.

Beneficient (NASDAQ: BENF) has issued a reminder to stockholders to cast their votes on proxy proposals before the Annual Meeting of Stockholders scheduled for April 30, 2025, at 9:00 a.m. Central Time. The deadline for voting is April 29, 2025, at 11:59 p.m. Central Time.

Stockholders can vote through multiple channels:

• Online at cstproxyvote.com
• By telephone at 1-866-894-0536
• By mailing proxy cards to the Corporate Secretary in Dallas

The virtual meeting will be held at cstproxy.com/beneficient/2025. The Board of Directors recommends voting in favor of all proposals, considering them in the best interests of the Company and stockholders. Previously submitted proxies remain valid unless revoked. Meeting quorum requirements must be met for the annual meeting to proceed.